Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL734953

O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.c1ccc([P+](O[P+](c2ccccc2)(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.46
PTPN1 P18031 1/20 0.38
ACHE P22303 8/20 0.36
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34
KCNH2 Q12809 7/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraphenylphosphonium SCHEMBL21957774 0.82 GPR3 (0.50) GPR3PTPN1ACHECA1CA2
Trifluoromethanesulfonic Acid SCHEMBL14834168 0.76 GPR3 (0.44) GPR3PTPN1ACHECA1CA2
Trifluoromethanesulfonic Acid SCHEMBL4457250 0.74 GPR3 (0.43) GPR3PTPN1ACHECA1CA2
Bromide SCHEMBL3314842 0.73 HIF1A (0.41)
Trifluoromethanesulfonic Acid SCHEMBL7749104 0.73 GPR3 (0.42) GPR3PTPN1
Trifluoromethanesulfonic Acid SCHEMBL6923668 0.73 GPR3 (0.53) GPR3PTPN1ACHECA1CA2
Trifluoromethanesulfonic Acid SCHEMBL8088040 0.73 GPR3 (0.53) GPR3PTPN1ACHECA1CA2
Biphenyl SCHEMBL31361248 0.73 PTPN1 (0.56) GPR3PTPN1CA1CA2CA5A
Trifluoromethanesulfonic Acid SCHEMBL6560666 0.71 GPR3 (0.57) GPR3PTPN1ACHECA1CA2
Trifluoromethanesulfonic Acid SCHEMBL9618033 0.71 GPR3 (0.52) GPR3PTPN1ACHECA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080031848-A1 Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds ELAN PHARMACEUTICALS, INC. 2008-02-07 US claimed
US-12084456-B2 Isocarbostyril alkaloids and functionalization thereof THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2024-09-10 US disclosed
US-20220251071-A1 METHOD TO MAKE SMALL-MOLECULE MURINE DOUBLE MINUTE 2 PROTEIN (MDM2)-DEGRADING COMPOUNDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM WISCONSIN ALUMNI RESEARCH FOUNDATION 2022-08-11 US disclosed
US-20220064176-A1 ISOCARBOSTYRIL ALKALOIDS AND FUNCTIONALIZATION THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-03-03 US disclosed
US-8138272-B2 Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds ELAN PHARMACEUTICALS, INC. (US) 2012-03-20 US disclosed
US-20080031848-A1 Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds ELAN PHARMACEUTICALS, INC. 2008-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080031848-A1 Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds PIGO, MANBA, OAT GPR3 4129/4885PTPN1 4579/4885ACHE 398/4885
US-20220064176-A1 ISOCARBOSTYRIL ALKALOIDS AND FUNCTIONALIZATION THEREOF NISCH, CIAPIN1, CA7 GPR3 4062/4885PTPN1 4686/4885ACHE 286/4885
US-12084456-B2 Isocarbostyril alkaloids and functionalization thereof NISCH, CIAPIN1, CA7 GPR3 4062/4885PTPN1 4686/4885ACHE 286/4885
US-20220251071-A1 METHOD TO MAKE SMALL-MOLECULE MURINE DOUBLE MINUTE 2 PROTEIN (MDM2)-DEGRADING COMPOUNDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MDM2, TP53, MYCBP2 GPR3 4669/4885PTPN1 3590/4885ACHE 4586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.